New alliance aims to accelerate development of future medicines Novo Nordisk has entered a strategic partnership with Amazon Web Services (AWS) to accelerate drug...

Phase 3 study shows strong efficacy Definium Therapeutics has announced positive topline results from Voyage, its first phase 3 study of DT120 ODT in adults with ...

Investment in new premises in London reflects significant milestone in Company's growth, following $20 million Series B financing Supports rapid scale-up and dev...

Final results from the CNS-102 study, published in Scientific Reports, show that the at-home NeuLogiq® Platform can be deployed successfully in patients with signif...

Accreditation strengthens ECI's ability to provide trusted laboratory testing and integrated support to life sciences organizations ECI announced today th...

Proven track record of consistent high quality confirmed at Pace® Life Sciences Pace® Life Sciences, a U.S.-based, FDA-registered GMP analytical testing labo...

Acquisition adds oral solid dose development and small‑scale commercial manufacturing, expanding Codis’ integrated spray dry offering in Europe Nottingham team b...

Expanded agenda brings together global pharmaceutical leaders to tackle manufacturing transformation, future therapies, AI and sustainability Informa Markets has ...

Science Based Targets initiative (SBTi) validation provides independent confirmation of Axplora's emissions reduction targets.   Targets reinforce Axplora's comm...

CPHI & PMEC Shenzhen 2026 is set to welcome its most international audience to date, reflecting growing global interest in South China's rapidly evolving pharmac...